Feb 15, 2019
We provided an overview of the field of neuropsychology in Episode 2, but we wanted to run it by someone outside the field to see if anything was unclear or if other questions came up. This episode is a Q & A with someone without any background in neuropsychology. We discuss lots of topics, such as the difference...
Feb 1, 2019
Clinical trials in Alzheimer’s disease frequently include the measurement of risk genes (i.e., the APOE e4 allele), and advancements in direct-to-consumer genetic testing (e.g., 23andMe) have made these biological data widely available to the public. Is it helpful or harmful for clinicians to disclose information on...